This company listing is no longer active
Biotricity Beheer
Beheer criteriumcontroles 2/4
Biotricity's CEO is Waqaas Al-Siddiq, appointed in Jul 2014, has a tenure of 10.08 years. total yearly compensation is $1.25M, comprised of 38.3% salary and 61.7% bonuses, including company stock and options. directly owns 3.49% of the company’s shares, worth €300.95K. The average tenure of the management team and the board of directors is 6.8 years and 7 years respectively.
Belangrijke informatie
Waqaas Al-Siddiq
Algemeen directeur
US$1.3m
Totale compensatie
| Percentage CEO-salaris | 38.3% |
| Dienstverband CEO | 10.1yrs |
| Eigendom CEO | 3.5% |
| Management gemiddelde ambtstermijn | 6.8yrs |
| Gemiddelde ambtstermijn bestuur | 7yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Mar 31 2024 | US$1m | US$480k | -US$15m |
| Dec 31 2023 | n/a | n/a | -US$15m |
| Sep 30 2023 | n/a | n/a | -US$17m |
| Jun 30 2023 | n/a | n/a | -US$18m |
| Mar 31 2023 | US$1m | US$480k | -US$20m |
| Dec 31 2022 | n/a | n/a | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$23m |
| Jun 30 2022 | n/a | n/a | -US$29m |
| Mar 31 2022 | US$887k | US$480k | -US$30m |
| Dec 31 2021 | n/a | n/a | -US$30m |
| Sep 30 2021 | n/a | n/a | -US$27m |
| Jun 30 2021 | n/a | n/a | -US$19m |
| Mar 31 2021 | US$891k | US$390k | -US$16m |
| Dec 31 2020 | n/a | n/a | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$14m |
| Jun 30 2020 | n/a | n/a | -US$13m |
| Mar 31 2020 | US$2m | US$390k | -US$11m |
| Dec 31 2019 | n/a | n/a | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | US$2m | US$360k | -US$9m |
| Dec 31 2018 | n/a | n/a | -US$10m |
| Sep 30 2018 | n/a | n/a | -US$9m |
| Jun 30 2018 | n/a | n/a | -US$9m |
| Mar 31 2018 | US$1m | US$310k | -US$9m |
Compensatie versus markt: Waqaas's total compensation ($USD1.25M) is above average for companies of similar size in the German market ($USD534.42K).
Compensatie versus inkomsten: Waqaas's compensation has increased whilst the company is unprofitable.
CEO
Waqaas Al-Siddiq (39 yo)
10.1yrs
Tenure
US$1,254,153
Compensatie
Dr. Waqaas Al-Siddiq, PhD, has founded Biotricity Inc.(formerly known as iMedical Innovations Inc.) in July 2014 and has been its Chairman, President and Chief Executive Officer since July 2014. Dr. Al-Sid...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 10.1yrs | US$1.25m | 3.49% € 300.9k | |
| Chief Financial Officer | 6.8yrs | US$562.00k | 1.22% € 105.1k | |
| Senior Director of Operations | no data | geen gegevens | geen gegevens | |
| Director of Business Development | no data | geen gegevens | geen gegevens | |
| Vice President of Sales & Strategy | no data | geen gegevens | geen gegevens | |
| Chief Development Officer | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Healthcare Solutions | less than a year | geen gegevens | geen gegevens |
6.8yrs
Gemiddelde duur
Ervaren management: QB00's management team is seasoned and experienced (6.8 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 10.1yrs | US$1.25m | 3.49% € 300.9k | |
| Chair of Scientific & Medical Alliance Board and Chair of Science Alliance Board | 4.4yrs | geen gegevens | geen gegevens | |
| Member of the Board of Advisors | 8.3yrs | geen gegevens | geen gegevens | |
| Independent Director | 2.3yrs | US$32.62k | 0.16% € 13.6k | |
| Independent Director | 8.3yrs | US$60.00k | 1.33% € 114.7k | |
| Member of the Board of Advisors | 8.2yrs | geen gegevens | geen gegevens | |
| Member of the Board of Advisors | 8.3yrs | geen gegevens | geen gegevens | |
| Member of the Board of Advisors | 8.2yrs | geen gegevens | geen gegevens | |
| Member of Scientific & Medical Alliance Board | 5.8yrs | geen gegevens | geen gegevens | |
| Member of Scientific & Medical Alliance Board | 5.8yrs | geen gegevens | geen gegevens | |
| Member of Scientific & Medical Alliance Board | 5.8yrs | geen gegevens | geen gegevens | |
| Member of Scientific & Medical Alliance Board | 5.8yrs | geen gegevens | geen gegevens |
7.0yrs
Gemiddelde duur
64yo
Gemiddelde leeftijd
Ervaren bestuur: QB00's board of directors are considered experienced (7 years average tenure).